Dr Dorff presented early data for the first 12 CAR-T trial patients at the American Society of Clinical Oncology (ASCO) meeting this weekend. For those of you interested in wading through the data, here's the link to the abstract
The short version is that early results are promising, and modifications to the procedure allows them to control cystitis snd Cytokine Release Syndrome (CRS).
Written by
Javelin18
To view profiles and participate in discussions please or .
Best wishes for the success of this trial/treatment for you, Javelin! And many thanks in advance for keeping us posted! Ive been interested in the CAR-T since I first read about it. It seems to have significant potential.
Wishing you wellness throughout and beyond the trial. And will be watching for your updates along the way. Thanks for participating and helping to pave the way toward more effective treatments!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.